ESPR

NASDAQ · Pharmaceuticals

Esperion Therapeutics Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.15

-0.02 (-0.63%)

ESPR News1 articles

Esperion to Be Acquired by ARCHIMED in $1.1 Billion Deal, Shares Jump 56%

ARCHIMED will acquire Esperion Therapeutics for $3.16 per share in cash plus contingent value rights, valuing the deal at up to $1.1 billion. Esperion shares surged 56% on the news.